Results 111 to 120 of about 18,784 (212)

FDG and FAPI PET–based response evaluation to reduced‐dose nivolumab in pleural mesothelioma: A case report

Clinical Physiology and Functional Imaging, Volume 46, Issue 2, March 2026.
Abstract Reliable tools for objective response assessment are essential in pleural mesothelioma treated with immunotherapy. We report on a 75‐year‐old man with sarcomatoid pleural mesothelioma who received a reduced nivolumab dose after developing a hypersensitivity reaction during the first infusion.
Morten Bentestuen, Anne H. Thostrup, Weronika M. Szejniuk, Zsuzsanna Takacs‐Szabo, Thor L. Rasmussen, Helle D. Zacho   +5 more
wiley   +1 more source

Ultrasound and MRI abdominal fat distribution and its associations with metabolic conditions in adults with abdominal obesity

Diabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 2061-2074, March 2026.
Abstract Aims To evaluate the accuracy of abdominal fat distribution of subcutaneous (SAT) and visceral adipose tissue (VAT) assessed by ultrasound (US) compared to magnetic resonance imaging (MRI), as the gold standard technique. Additionally, to assess the association between abdominal fat distribution measured by US and metabolic conditions in ...
Claudia Jiménez‐ten Hoevel, Maria Besora‐Moreno, Judit Queral, Elisabet Llauradó, Rosa M. Valls, Rosa Solà, Anna Pedret   +6 more
wiley   +1 more source

Second Asian Consensus Report on Functional Dyspepsia (2025): Updated Recommendations

Journal of Gastroenterology and Hepatology, Volume 41, Issue 3, Page 832-853, March 2026.
ABSTRACT Background Functional dyspepsia (FD) is a common gastrointestinal disorder that significantly impacts patients' quality of life. Over a decade ago, the Asian Neurogastroenterology and Motility Association (ANMA) and the Asian Pacific Association of Gastroenterology (APAGE) jointly developed the first Asian consensus report on FD.
Sanjiv Mahadeva, Kewin Tien Ho Siah, Uday C. Ghoshal, Hidekazu Suzuki, Yeong Yeh Lee, Kee Huat Chuah, Vincent Chung, Linda Zhong, Benjamin Wei‐Rong Tay, Ban Hong Ang, Ram Prasad Sinnanaidu, Tao Bai, Tadayuki Oshima, Tanisa Patcharatrakul, Sanjeev Sachdeva, Ping‐Huei Tseng, Jinsong Liu, Yinglian Xiao, Ratha‐Korn Vilaichone, Joon Seong Lee, Jung‐Hwan Oh, Ari Fahrial Syam, Ching Liang Lu, Tiing Leong Ang, In‐Kyung Sung, Xiao‐Hua Hou, Kentaro Sugano, Justin Wu, Hiroto Miwa   +28 more
wiley   +1 more source

Perceived Utility of Cognitive Behavioral Therapy in People With Bowel Disorders of Gut–Brain Interaction

Neurogastroenterology &Motility, Volume 38, Issue 3, March 2026.
In an online survey, 70% of adults view cognitive behavioral therapy (CBT) as helpful. Cost, access, and time constraints are barriers. Those with bowel disorders of gut–brain interaction (DGBI) are familiar with CBT, but only those with non‐DGBI gastrointestinal diseases are more frequently offered CBT than controls.
Diego Izquierdo Veraza, Mohammed Rayyan Waseem, John Venezia, Anne Mary Montero, Sean Jones, Jhalka Kadariya, Anita Gupta, Huiping Xu, Andrea Shin   +8 more
wiley   +1 more source

[Visceral hypersensitivity: a concept within our reach].

Revista medica de Chile, 2003
Despite significant advances in the recognition of etiological factors and pathological mechanisms, the pathophysiology of functional gastrointestinal disorders (FGD) is still not fully understood. Visceral hypersensitivity has been recognized as a characteristic of patients with FGD, especially in patients with irritable bowel syndrome (IBS). Visceral
Rodrigo, Quera, Jorge, Valenzuela
openaire   +1 more source

Predominant Symptom in Gastroparesis: Relationships to Quality of Life, Treatments, and Outcome

Neurogastroenterology &Motility, Volume 38, Issue 3, March 2026.
In patients with gastroparesis, the most common predominant symptoms were nausea, vomiting, and abdominal pain. Impaired QOL varied with patients' predominant symptom, with abdominal pain associated with poorer QOL. Over 48 weeks, GSCI improved ≥ 1 in a minority of patients, more often in patients with predominant symptoms of nausea and bloating, less ...
Henry P. Parkman, Laura A. Wilson, William L. Hasler, Madhusudan Grover, Bruno P. Chumpitazi, Helen Burton‐Murray, Irene Sarosiek, Baha Moshiree, Geoffrey A. Preidis, Robert J. Shulman, Laura A. Miriel, Dave Shade, Braden Kuo, Richard W. McCallum, Thomas L. Abell, Pankaj J. Pasricha, for the NIDDK Gastroparesis Clinical Research Consortium   +16 more
wiley   +1 more source

Altered peripheral CRY1 gene expression may contribute to both organic and functional gastrointestinal disease

Experimental Physiology, Volume 111, Issue 3, Page 946-962, 1 March 2026.
ABSTRACT Gastrointestinal conditions such as irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD) are characterized by alterations in physiological and immune functions. Given the circadian clock influences gastrointestinal physiology and immunity, we hypothesized that the peripheral circadian clock is altered in these patients and ...
Sophie Fowler, Gemma M. Paech, Emily C. Hoedt, Jennifer C. Pryor, Cheenie Nieva, Jessica K. Bruce, Prema M. Nair, Guy D. Eslick, Simonne Sherwin, Peter Pockney, Nicholas J. Talley, Grace L. Burns, Simon Keely   +12 more
wiley   +1 more source

Reviewing the Peripheral and Central Mechanisms of Visceral Hypersensitivity in Intestinal Disorders. [PDF]

Int J Med Sci
Tang W, Wang J, Wang W, Xue J, Wang Y, Jiang F, Kechiyerunda DC, Gao S, Yuan T, Guo F.   +9 more
europepmc   +1 more source

Enteric glia promote visceral hypersensitivity during inflammation through intercellular signaling with gut nociceptors. [PDF]

Sci Signal, 2023
Morales-Soto W, Gonzales J, Jackson WF, Gulbransen BD.   +3 more
europepmc   +1 more source

The efficacy and neural mechanism of acupuncture therapy in the treatment of visceral hypersensitivity in irritable bowel syndrome. [PDF]

Front Neurosci, 2023
Yang Y, Wang J, Zhang C, Guo Y, Zhao M, Zhang M, Li Z, Gao F, Luo Y, Wang Y, Cao J, Du M, Wang Y, Lin X, Xu Z.   +14 more
europepmc   +1 more source